What is SecondWave Systems?
SecondWave Systems is at the forefront of developing a novel, ultrasound-based wearable neuromodulation platform. This groundbreaking technology aims to provide patients and their physicians with a new therapeutic option for managing debilitating or life-threatening diseases. The company's focus on non-invasive neuromodulation positions it as a key player in the rapidly evolving medtech landscape, addressing critical unmet needs in patient care.
How much funding has SecondWave Systems raised?
SecondWave Systems has raised a total of $17.4M across 3 funding rounds:
Angel/Seed
$7.4M
Other Financing Round
$3M
Series A
$7M
Angel/Seed (2021): $7.4M with participation from Department of Defense - Defense Advanced Research Projects Agency and U.S. Department of Defense
Other Financing Round (2024): $3M led by Advanced Research Projects Agency for Health and Department of Defense - Defense Advanced Research Projects Agency
Series A (2025): $7M supported by Scientific Health Development, Treo Ventures, Sectoral Asset Management, and Carlson School of Management - University of Minnesota
Key Investors in SecondWave Systems
Department of Defense - Defense Advanced Research Projects Agency
DARPA is a key backer, known for funding high-risk, high-reward research projects that have the potential for significant technological breakthroughs. Their involvement suggests a strong alignment with SecondWave Systems' innovative and potentially disruptive technology.
Advanced Research Projects Agency for Health
ARPA-H is dedicated to accelerating biomedical and health breakthroughs. Their investment in SecondWave Systems highlights the potential of the company's platform to deliver transformative health solutions and address significant public health challenges.
Scientific Health Development
Scientific Health Development is a venture capital firm specializing in early-stage medtech companies. Their investment indicates a belief in SecondWave Systems' potential to address unmet clinical needs with innovative, patient-outcome-enhancing technologies.
What's next for SecondWave Systems?
The substantial capital infusion, particularly the recent strategic investment, signals SecondWave Systems' readiness to scale its operations and accelerate product development. This backing is expected to fuel advancements in clinical trials, regulatory approvals, and market penetration. The company's strategic partnerships and the continued support from its investor base suggest a clear path towards commercialization and establishing a significant market presence in the neuromodulation sector.
See full SecondWave Systems company page
